Parkinson’s disease, a neurodegenerative disorder affecting almost 10 million people worldwide, has long been linked to the brain. However, new research suggests that gut microbes play a significant role in its onset and progression. A recent study found that decreased levels of riboflavin (vitamin B2) and biotin (vitamin B7) in the gut may be a key factor.
Researchers at Nagoya University identified specific gut microbes linked to these deficiencies, which were associated with symptoms such as constipation, sleep problems, and dementia. The study found that high doses of vitamin B may help alleviate PD symptoms and slow disease progression.
The researchers propose that healthy gut microbiomes could also provide protection against Parkinson’s disease. Furthermore, reducing toxic pollutants in the environment may help mitigate the effects of the disease.
While individual results may vary, the study suggests that gut microbiota analysis and fecal metabolite analysis could be used to identify individuals with specific deficiencies and administer targeted supplements. This breakthrough research has potential implications for developing new treatments for Parkinson’s disease.
Note: The article has been simplified and restructured to make it more concise and engaging, while retaining all essential information. The title is also optimized for SEO, limited to 10 words or fewer.
Source: https://www.sciencealert.com/parkinsons-link-to-gut-bacteria-hints-at-an-unexpected-simple-treatment